Increased activities of Na+/K+-ATPase and Ca2+/Mg2+-ATPase in the frontal cortex and cerebellum of autistic individuals

Life Sciences

Volumn 85, Issue 23-26, 2009, Pages 788-793

  Ji, Lina ^a   Chauhan, Abha ^a   Brown, W Ted ^a   Chauhan, Ved ^a  

^a NEW YORK STATE INSTITUTE FOR BASIC RESEARCH IN DEVELOPMENTAL DISABILITIES   (United States)

Author keywords

Autism spectrum disorders; Ca2+ Mg2+ ATPase; Na+ K+ ATPase

Indexed keywords

ADENOSINE TRIPHOSPHATASE (CALCIUM MAGNESIUM); ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); PHOSPHATE;

ADOLESCENT; ARTICLE; AUTISM; BRAIN HOMOGENATE; BRAIN REGION; CADAVER; CALCIUM CELL LEVEL; CEREBELLUM; CHILD; CONTROLLED STUDY; ENZYME ACTIVITY; FRONTAL CORTEX; HUMAN; HUMAN TISSUE; HYDROLYSIS; OCCIPITAL CORTEX; PARIETAL LOBE; SCHOOL CHILD; SIGNAL TRANSDUCTION; TEMPORAL LOBE; TISSUE SPECIFICITY;

ADOLESCENT; AGE FACTORS; AUTISTIC DISORDER; CA(2+) MG(2+)-ATPASE; CEREBELLUM; CHILD; HUMANS; PREFRONTAL CORTEX; REFERENCE STANDARDS; SIGNAL TRANSDUCTION; SODIUM-POTASSIUM-EXCHANGING ATPASE; UP-REGULATION;

EID: 70649102945     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2009.10.008     Document Type: Article

References (56)

1. Aamodt S.M., and Constantine-Paton M. The role of neural activity in synaptic development and its implications for adult brain function. Adv. Neurol. 79 (1999) 133-144
2. Amiet C., Gourfinkel-An I., Bouzamondo A., Tordjman S., Baulac M., Lechat P., Mottron L., and Cohen D. Epilepsy in autism is associated with intellectual disability and gender, evidence from a meta-analysis. Biol. Psychiatry 64 (2008) 577-582
3. Bell J.G., Sargent J.R., Tocher D.R., and Dick J.R. Red blood cell fatty acid compositions in a patient with autistic spectrum disorder, a characteristic abnormality in neurodevelopmental disorders?. Prostaglandins Leukot. Essent. Fat. Acids 63 (2000) 21-25
4. Bell J.G., MacKinlay E.E., Dick J.R., MacDonald D.J., Boyle R.M., and Glen A.C. Essential fatty acids and phospholipase A2 in autistic spectrum disorders. Prostaglandins Leukot. Essent. Fat. Acids 71 (2004) 201-204
5. Belmont M.K., Cook Jr. E.H., Anderson G.M., Rubenstein J.L., Greenough W.T., Beckel-Mitchener A., Courchesne E., Boulanger L.M., Powell S.B., Levitt P.R., Perry E.K., Jiang Y.H., DeLorey T.M., and Tierney E. Autism as a disorder of neural information processing, directions for research and targets for therapy. Mol. Psychiatry 9 (2004) 646-663
6. Berridge M.J. Inositol trisphosphate and calcium oscillations. Adv. Second Messenger Phosphoprot. Res. 26 (1992) 211-223
7. 2+ stores and cell responsiveness. Am. J. Physiol. 264 (1993) C1367-C1387
8. Blaustein M.P., and Lederer W.J. Sodium/calcium exchange, its physiological implications. Physiol. Rev. 79 (1999) 763-854
9. Brines M.L., Tabuteau H., Sundaresan S., Kim J., Spencer D.D., and de Lanerolle N. Regional distributions of hippocampal Na+, K+-ATPase, cytochrome oxidase, and total protein in temporal lobe epilepsy. Epilepsia 36 (1995) 371-383
10. Carafoli E., Garcia-Martin E., and Guerini D. The plasma membrane calcium pump, recent developments and future perspectives. Experientia 52 (1996) 1091-1100
11. Christo P.J., and el Mallakh R.S. Possible role of endogenous ouabain-like compounds in the pathophysiology of bipolar illness. Med. Hypotheses 41 (1993) 378-383
12. Cline H.T. Dendritic arbor development and synaptogenesis. Curr. Opin. Neurobiol. 11 (2001) 118-126
13. Cooper E.C., and Jan L.Y. Ion channel genes and human neurological disease, recent progress, prospects, and challenges. Proc Natl Acad Sci U.S.A. 96 (1999) 4759-4766
14. Courchesne E., Redcay E., Morgan J.T., and Kennedy D.P. Autism at the beginning, microstructural and growth abnormalities underlying the cognitive and behavioral phenotype of autism. Dev. Psychopathol. 17 (2005) 577-597
15. +-ATPase activity of rat brain during Crush syndrome. Neurochem. Res. 32 (2007) 1843-1848
16. DiCicco-Bloom E., Lord C., Zwaigenbaum L., Courchesne E., Dager S.R., Schmitz C., Schultz R.T., Crawley J., and Young L.J. The developmental neurobiology of autism spectrum disorder. J. Neurosci. 26 (2006) 6897-6906
17. + ATPase activity in the rat hippocampus, a study in the pilocarpine model of epilepsy. Neurochem. Int. 28 (1996) 497-500
18. Fiske C.H., and Subbarow Y. The colorimetric determination of phosphorus. J. Biol. Chem. 66 (1953) 375-400
19. Fulle S., Belia S., Vecchiet J., Morabito C., Vecchiet L., and Fano G. Modification of the functional capacity of sarcoplasmic reticulum membranes in patients suffering from chronic fatigue syndrome. Neuromuscul. Disord. 13 (2003) 479-484
20. Gargus J.J. Genetic calcium signaling abnormalities in the central nervous system, seizures, migraine, and autism. Ann. N.Y. Acad. Sci. 1151 (2009) 133-156
21. Glaaser I.W., Bankston J.R., Liu H., Tateyama M., and Kass R.S. A carboxyl-terminal hydrophobic interface is critical to sodium channel function. Relevance to inherited disorders. J. Biol. Chem. 281 (2006) 24015-24023
22. 2+-ATPase activity in erythrocyte membrane in hypercalciuric nephrolithiasic patients. Nepharology 7 (2009) 12-17
23. Hemara-Wahanui A., Berjukow S., Hope C.I., Dearden P.K., Wu S.B., Wilson-Wheeler J., Sharp D.M., Lundon-Treweek P., Clover G.M., Hoda J.C., Striessnig J., Marksteiner R., Hering S., and Maw M.A. A CACNA1F mutation identified in an X-linked retinal disorder shifts the voltage dependence of Cav1.4 channel activation. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 7553-7558
24. Hope C.I., Sharp D.M., Hemara-Wahanui A., Sissingh J.I., Lundon P., Mitchell E.A., Maw M.A., and Clover G.M. Clinical manifestations of a unique X-linked retinal disorder in a large New Zealand family with a novel mutation in CACNA1F, the gene responsible for CSNB2. Clin. Exp. Ophthalmol. 33 (2005) 129-136
25. Jacobsen N.J., Lyons I., Hoogendoorn B., Burge S., Kwok P.Y., O'Donovan M.C., Craddock N., and Owen M.J. ATP2A2 mutations in Darier's disease and their relationship to neuropsychiatric phenotypes. Hum. Mol. Genet. 8 (1999) 1631-1636
26. Kamiya K., Kaneda M., Sugawara T., Mazaki E., Okamura N., Montal M., Makita N., Tanaka M., Fukushima K., Fujiwara T., Inoue Y., and Yamakawa K. A nonsense mutation of the sodium channel gene SCN2A in a patient with intractable epilepsy and mental decline. J. Neurosci. 24 (2004) 2690-2698
27. 2+ sensitivity of sodium channels. J. Biol. Chem. 279 (2004) 45004-45012
28. 2+ fluctuations. J. Neurobiol. 37 (1998) 110-130
29. Lamb J.A., Moore J., Bailey A., and Monaco A.P. Autism, recent molecular genetic advances. Hum. Mol. Genet. 9 (2000) 861-868
30. Laumonnier F., Roger S., Guerin P., Molinari F., M'rad R., Cahard D., Belhadj A., Halayem M., Persico A.M., Elia M., Romano V., Holbert S., Andres C., Chaabouni H., Colleaux L., Constant J., Le Guennec J.Y., and Briault S. Association of a functional deficit of the BKCa channel, a synaptic regulator of neuronal excitability, with autism and mental retardation. Am. J. Psychiatry 163 (2006) 1622-1629
31. Lingrel J.B., Williams M.T., Vorhees C.V., and Moseley A.E. Na, K-ATPase and the role of alpha isoforms in behavior. J. Bioenerg. Biomembranes 39 (2007) 385-389
32. Lord C., Cook E.H., Leventhal B.L., and Amaral D.G. Autism spectrum disorders. Neuron 28 (2000) 355-363
33. MacDonell L.E., Skinner F.K., Ward P.E., Glen A.I., Glen A.C., Macdonald D.J., Boyle R.M., and Horrobin D.F. Increased levels of cytosolic phospholipase A2 in dyslexics. Prostaglandins Leukot. Essent. Fat. Acids 63 (2000) 37-39
34. +-ATPase activity in the rat brain is mediated through alpha1A-adrenoceptor possibly by dephosphorylation of the enzyme. J. Neurochem. 74 (2000) 1574-1578
35. McCormick D.A., and Huguenard J.R. Electrophysiology of Neuron: An Interactive Tutorial (1994), Oxford University Press, Oxford 12
36. Moody W.J., and Bosma M.M. Ion channel development, spontaneous activity, and activity-dependent development in nerve and muscle cells. Physiol. Rev. 85 (2005) 883-941
37. Nagy A.K., Houser C.R., and Delgado-Escueta A.V. Synaptosomal ATPase activities in temporal cortex and hippocampal formation of humans with focal epilepsy. Brain Res. 529 (1990) 192-201
38. 2+ release channels. Cell Calcium 19 (1996) 375-381
39. + ATPase alpha subunit mutants. J. Neurosci. 23 (2003) 1276-1286
40. Pietrini G., Matteoli M., Banker G., and Caplan M.J. Isoforms of the Na, K-ATPase are present in both axons and dendrites of hippocampal neurons in culture. Proc. Natl. Acad. Sci. U. S. A. 89 (1992) 8414-8418
41. Regunathan S., and Sundaresan R. Effects of organic and inorganic lead on synaptosomal uptake, release, and receptor binding of glutamate in young rats. J. Neurochem. 44 (1985) 1642-1646
42. +ATPase activity is increased in the hippocampus after multiple status epilepticus induced by pilocarpine in developing rats. Brain Res. 1138 (2007) 203-207
43. +-ATPase in the brain. Epilepsia 33 (1992) 58-64
44. Represa A., and Ben Ari Y. Trophic actions of GABA on neuronal development. Trends Neurosci. 28 (2005) 278-283
45. Rose A.M., and Valdes Jr. R. Understanding the sodium pump and its relevance to disease. Clin. Chem. 40 (1994) 1674-1685
46. Somjen G.G. Ion regulation in the brain: implications for pathophysiology. Neuroscientist 8 (2002) 254-267
47. 2+ spikes specify transmitter choice. Trends Neurosci. 27 (2004) 415-421
48. Splawski I., Timothy K.W., Sharpe L.M., Decher N., Kumar P., Bloise R., Napolitano C., Schwartz P.J., Joseph R.M., Condouris K., Tager-Flusberg H., Priori S.G., Sanguinetti M.C., and Keating M.T. CaV.1.2 calcium channel dysfunction causes a multisystem disorder including arrhythmia and autism. Cell 119 (2004) 19-31
49. Splawski I., Timothy K.W., Decher N., Kumar P., Sachse F.B., Beggs A.H., Sanguinetti M.C., and Keating M.T. Severe arrhythmia disorder caused by cardiac L-type calcium channel mutations. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 8089-8096
50. Splawski I., Yoo D.S., Stotz S.C., Cherry A., Clapham D.E., and Keating M.T. CACNA1H mutations in autism spectrum disorders. J. Biol. Chem. 281 (2006) 22085-22091
51. Takser L., Campagna D., Blot P., and Huel G. Could monoamine plasma levels and erythrocyte membrane ATPase activities at birth be predictive for future hand performance?. Pediatr. Res. 54 (2003) 358-363
52. Ward P.E. Potential diagnostic aids for abnormal fatty acid metabolism in a range of neurodevelopmental disorders. Prostaglandins Leukot. Essent. Fat. Acids 63 (2000) 65-68
53. Wassink T.H., Piven J., Vieland V.J., Huang J., Swiderski R.E., Pietila J., Braun T., Beck G., Folstein S.E., Haines J.L., and Sheffield V.C. Evidence supporting WNT2 as an autism susceptibility gene. Am. J. Med. Genet. 105 (2001) 406-413
54. Wayman G.A., Impey S., Marks D., Saneyoshi T., Grant W.F., Derkach V., and Soderling T.R. Activity-dependent dendritic arborization mediated by CaM-kinase I activation and enhanced CREB-dependent transcription of Wnt-2. Neuron 50 (2006) 897-909
55. Weiss L.A., Escayg A., Kearney J.A., Trudeau M., MacDonald B.T., Mori M., Reichert J., Buxbaum J.D., and Meisler M.H. Sodium channels SCN1A, SCN2A and SCN3A in familial autism. Mol. Psychiatry 8 (2003) 186-194
56. West A.E., Chen W.G., Dalva M.B., Dolmetsch R.E., Kornhauser J.M., Shaywitz A.J., Takasu M.A., Tao X., and Greenberg M.E. Calcium regulation of neuronal gene expression. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 11024-11031